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Abstract
OBJECTIVE: To explore correlations between the
symptoms of constipation and abdominal disten-
tion and severity of chronic obstructive pulmonary
disease (COPD) in patients with stable disease.
METHODS: We studied 191 patients with stable
COPD (according to defined criteria) in this
cross-sectional study from four three-level class A
Chinese medicine hospitals in China. We built an
Epidata 3.0 database and performed statistical anal-
ysis with SPSS, version 17.0. We analyzed correla-
tions between the frequency of lower gastrointesti-
nal tract symptoms (constipation and abdominal
distention) and scores for major pulmonary symp-
toms (cough, sputum and wheezing) based on the
St. George's Respiratory Questionnaire (SGRQ),
6-minute walking distance (6MWD) and frequency
of acute exacerbations of COPD (AECOPD).
RESULTS: In addition to their pulmonary symp-
toms, 39.79% and 40.31% of study patients with
stable COPD reported constipation and abdominal
distention, respectively. Scores for major pulmo-
nary symptoms (cough, sputum and wheezing), AE-
COPD and SGRQ values in patients with constipa-
tion and abdominal distention were significantly
greater, and the 6MWD markedly shorter, than in
those without them. According to Pearson's correla-
tion analysis, there were strong correlations be-
tween these lower gastrointestinal tract symptoms
and scores for pulmonary symptoms, SGRQ, 6MWD
and AECOPD.
CONCLUSION: Lower gastrointestinal tract symp-
toms such as constipation and abdominal disten-
tion can adversely affect pulmonary symptoms, fre-
quency of acute exacerbations and quality of life in
patients with stable COPD.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD), a
common chronic respiratory disease, which prevalence
was 8.2%, making it the third leading cause of death in
China.1 Dyspnea and limitation of mobility are its
main clinical symptoms; these tend to worsen as the
disease progresses. COPD has recently been recognized
not only as an inflammatory respiratory disorder, but
also as a chronic systemic inflammatory syndrome. The
systemic inflammation causes a variety of abnormali-
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ties. Systemic comorbidities involving the cardiovascu-
lar, endocrine, and gastrointestinal systems and psycho-
logical disorders are prevalent in patients with ad-
vanced COPD. These disorders together with related
pulmonary complications have a great impact on pa-
tients' quality of life (QOL) and mortality.2 Some re-
searchers have found that upper gastrointestinal diseas-
es such as gastroesophageal reflux correlate closely with
acute exacerbations of COPD and QOL in patients
with stable COPD.3-5 Constipation and diarrhea are
disorders of the lower portion of the gastrointestinal
tract that manifest as changes in frequency of defeca-
tion and consistency of stools.6,7 Ludvigsson et al 8 re-
ported that patients with celiac disease have higher
COPD-associated morbidity, which could affect the
course of their disease; however, there is no published
research on correlations between constipation and ab-
dominal distention and COPD.
We performed cross-sectional questionnaire surveys in
four three-level class A Chinese medicine (CM) hospi-
tals in China and identified 191 patients with stable
COPD according to defined diagnostic and inclusion
criteria. We assessed the frequency of constipation and
abdominal distention in these patients and investigated
correlations between these symptoms and scores for
major pulmonary symptoms (cough, sputum and
wheezing), the St. George's respiratory questionnaire
(SGRQ), 6-min walking distance (6MWD) and fre-
quency of acute exacerbation of COPD (AECOPD).
We analyzed our findings to develop guidelines for clin-
ical prevention and treatment of COPD morbidity.
MATERIALS ANDMETHODS
Patients
One hundred and ninety-one outpatients and inpa-
tients with stable COPD were recruited from Novem-
ber 2009 to February 2013 from four three-level class
A CM hospitals in China. These comprised 58 patients
from Dongzhimen Hospital affiliated with Beijing Uni-
versity of Chinese Medicine (30.4%), 74 from Hebei
Provincial Hospital of Traditional Chinese Medicine
(38.7%), 39 from the Hospital Affiliated with Gansu
College of Traditional Chinese Medicine (20.4%), and
20 from the Hospital of Traditional Chinese Medicine
affiliated with Liaoning University of Traditional Chi-
nese Medicine (10.5% ). All the patients signed in-
formed consents.
Total 191 patients with stable COPD in the study:
132 men (69.11%) and 59 women (30.89%). The av-
erage age was 66.87 years (range, 45-80 years). Seven-
ty-seven patients (40.31% ) reported constipation, 76
(39.79%) abdominal distension and 85 (44.52%) nei-
ther of these two symptoms. The three groups were
similar in sex, age, lung function, smoking habit, and
body mass index (Table 1).
Selection criteria
Diagnostic criteria for stable COPD: The diagnostic
criteria for stable COPD were the Global Initiative for
Chronic Obstructive Lung Disease (2007)9 and Chron-
ic Obstructive Pulmonary Disease Diagnostic guides10
(COPDGroup,ChineseSocietyofRespiratoryDiseases).
Inclusion criteria
Patients meeting the following criteria were included in
the study: (a) diagnostic criteria for COPD; (b) stable
stage of COPD; (c) age between 18 and 80 years at in-
clusion; (d) voluntary participation and signed in-
formed consent.
Notes: data are presented as mean±SD or % (No.). AD (+): patients with abdominal distension; Constipation (+): patients with constipa-
tion; LGTS (-): patients without lower gastrointestinal tract symptoms (including abdominal distension and constipation). BMI: body
mass index; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second.
Variables
Mean age (year)
Gender
Tobacco status
Current
Past
Never
BMI (kg/m2)
Lung function
Male
Female
FEV1%
FEV1/FVC
AD (+)
(n=76)
64.0±10.2
57
19
8
36
32
23.1±2.5
54.2±15.3
63.6±13.8
Constipation (+)
(n=77)
65.7±9.8
59
18
8
37
32
22.6±2.5
56.4±17.4
64.2±13.1
LGTS (-)
(n=85)
63.4±9.4
56
29
14
42
29
23.1±2.4
59.0±13.8
61.6±6.4
t/χ2/Z
2.496
2.74
2.44
0.677
1.836
0.941
P
0.085
0.2539
0.6556
0.509
0.162
0.392
Table 1 Relevant patient variables
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Exclusion criteria
Patients meeting any of the following criteria were ex-
cluded from the study: (a) airflow limitation due to
bronchiectasis, cystic fibrosis, active tuberculosis, lung
cancer or other disorders; (b) concurrent other severe,
potentially fatal diseases such as mechanical intestinal
obstruction, peritonitis, hernia, intestinal stenosis, se-
vere hemorrhoids, post-colorectal surgery, anal mucosal
inflammatory edema, aneurysm, major intestinal bleed-
ing or perforation, colorectal cancer, anal fistula, severe
anemia including aplastic anemia, acute left heart fail-
ure, and acute cerebral hemorrhage; (c) pregnant or
breast-feeding; (d) psychiatric disorders or any type of
neural impairment (aphasia or cognitive impairment)
that rendered them unable to understand the nature,
scope and possible consequences of the study; and (e)
serious hepatic and renal diseases.
Questionnaire development
A questionnaire was developed based on previous na-
tional research (973 projects) titled Symptom Standard-
ization in Traditional Chinese Medicine, research of
published reports,11 a pilot survey and expert opinions.
It comprised measurement of relevant patient variables
including lung function, frequency of acute exacerba-
tions of COPD, 6MWD, scoring according to the
SGRQ, pulmonary symptom scoring (cough, sputum
and wheezing) and scoring of lower gastrointestinal
tract symptoms. The details are as follows:
Symptom scores
According to the Likert response scale12 and symptom
quantification and classification method in the Guide
to New Traditional Chinese Medicines Research,13 the
values of 0, 2, 4 and 6 were designated as denoting No,
Mild, Moderate and Severe, respectively; the higher the
score, the more serious the symptoms. Major pulmo-
nary symptoms (cough, sputum, wheezing) and lower
gastrointestinal tract symptoms (constipation and ab-
dominal distention) were evaluated and reported by pa-
tients accordingly.
Pulmonary function
Forced vital capacity (FVC), forced expiratory volume
in 1 second (FEV1), and percentage of the predicted
FEV1 (FEV1%) were assessed.
Frequency of AECOPD
AECOPD refers to sudden worsening of COPD symp-
toms (cough, phlegm and wheezing) that typically lasts
for several days and requires a change in medication.14
The frequency of AECOPD in 1 year was noted.
Six-minute walking distance
Standardized 6-minute walking tests (6MWTs) as spec-
ified by the American Thoracic Society15 were used to
measure the 6MWD, the distance walked on a flat sur-
face in 6 min. This patient-reported outcome measure
has been widely used for integrated assessment of pa-
tients with pulmonary and cardiac disease, both by cli-
nicians to monitor functional status and by affected in-
dividuals, who are thus able to monitor changes in
their functional capacity and self-manage. 16
SGRQ
Health-related quality of life was evaluated using the
SGRQ,17which contains 50 items in three domains,
namely symptoms, activity, and disease impact.
Data entry and statistical analysis
Data were entered by two independent researchers us-
ing EpiData 3.0 software ("The EpiData Association"
Odense, Denmark) to build the clinical database;
SPSS, version 17.0 (SPSS, Inc., Chicago, IL, USA) was
used to perform the statistical analyses. All statistical
tests were two-sided and P<0.05 was considered the
threshold for statistical significance. The χ2 test was
used for enumeration data. Data are presented as
mean± standard deviation (SD) ( xˉ ± s). Multiple sam-
ples were processed by the homogeneity of variance
test and comparison between groups by single factor
analysis of variance. Relationships between lower gas-
trointestinal tract symptoms (constipation and abdomi-
nal distention) and major pulmonary symptoms
(cough, sputum and wheezing), SGRQ, 6MWD and
frequency of AECOPD were assessed by Pearson corre-
lation analysis.
RESULTS
Pulmonary symptom scores
As shown in Table 2, scores for pulmonary symptoms
(cough, sputum and wheezing) in patients with consti-
pation were 3.7±1.1, 3.5±1.2, and 3.4±1.4, respective-
ly. In patients with abdominal distention, these scores
were 3.6±1.4, 3.2±1.5, and 3.4±1.7, respectively. Pul-
monary symptom scores were significantly higher for
patients with constipation and abdominal distention
than for patients without these symptoms (2.2 ± 1.6,
2.3±1.4, 1.7±1.6 for cough, sputum and wheezing, re-
spectively) (P<0.01 for each comparison).
Frequency of acute exacerbations of COPD
As shown in Table 3, the frequency of AECOPD in pa-
tients with constipation was 2.6 ± 1.4, and in patients
with abdominal distention 2.6±1.6. These frequencies
were significantly higher than those in patients without
constipation and abdominal distention (1.6 ± 1.2) (P<
0.01).
Six-minute walking distance
As shown in Table 3, the 6MWD was (379.8±72.7) m
in COPD patients with constipation and (356.0 ±
53.8) m in those with abdominal distention. These dis-
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tances were significantly shorter than those in patients
without constipation and abdominal distention
(408.5±61.6) m (P<0.01).
Scores for SGRQ
As shown in Table 4, scores on SGRQ for symptoms,
activities, effects and total in stable COPD patients
with constipation were 64±18, 58±18, 52±20, and 56±
17, respectively. These scores were 63±17, 52±21, 48±
22, and 54±18, respectively, in stable COPD patients
with abdominal distention These scores were signifi-
cantly higher than those in patients without constipa-
tion and abdominal distention (49±23, 40±19, 28±16,
35±16) (P<0.01).
Correlation of scores for constipation and abdomi-
nal distention with QOL
According to Pearson's correlation analysis, there were
significant positive correlations between constipation
and pulmonary symptoms (cough, sputum and wheez-
ing), frequency of acute exacerbations of COPD and
scores on SGRQ for total, symptoms, activity, and im-
pact, the correlation coefficients being 0.355, 0.436,
0.337, 0.26, 0.187, 0.372, 0.411, and 0.437, respec-
tively. There was a significant negative correlation be-
tween constipation and 6MWT, the correlation coeffi-
cient being－0.517.
There were significantly positive correlations between
abdominal distention and pulmonary symptoms
(cough, sputum and wheezing), frequency of acute ex-
acerbation of COPD and scores on SGRQ for total,
symptoms, activity, and impact, the correlation coeffi-
cients being 0.410, 0.420, 0.508, 0.226, 0.298, 0.295,
0.512, and 0.462, respectively. There was a significant-
ly negative correlation between abdominal distention
Group
AD (+)
Constipation (+)
LGTS (-)
F
P
n
76
77
85
-
-
Symptom
63±17a
64±18a
49±23
15.375
0.000
Activity
52±21a
58±18a
40±19
20.325
0.000
Impact
48±22a
52±20a
28±16
36.279
0.000
Total
54±18a
56±17a
35±16
35.510
0.000
Table 4 SGRQ among groups ( xˉ ±s)
Notes: AD (+): patients with abdominal distension; constipation (+): patients with constipation; LGTS (-): patients without lower gastroin-
testinal tract symptoms (including abdominal distension and constipation). SGRQ: St. George's respiratory questionnaire. aP<0.01, com-
pared with patients without lower gastrointestinal tract symptoms (including abdominal distension and constipation).
Group
AD (+)
Constipation (+)
LGTS (-)
F
P
n
76
77
85
-
-
Frequency of acute exacerbation (No.)
2.6±1.6a
2.6±1.4a
1.6±1.2
14.641
0.000
6MWD (m)
356.0±53.8a
379.8±72.7b
408.5±61.6
11.979
0.000
Table 3 Frequency of acute exacerbation of COPD and 6MWD ( xˉ ±s)
Notes: AD (+): patients with abdominal distension; constipation (+): patients with constipation; LGTS (-): patients without lower gastroin-
testinal tract symptoms (including abdominal distension and constipation). COPD: chronic obstructive pulmonary disease; 6MWD:
6-minute walking distance. aP<0.01, bP<0.05, compared with the patients without lower gastrointestinal tract symptoms (including abdom-
inal distension and constipation).
Group
AD (+)
Constipation (+)
LGTS (-)
F
P
n
76
77
85
-
-
Cough
3.6±1.4a
3.7±1.1a
2.2±1.6
34.983
0.000
Sputum
3.2±1.5a
3.5±1.2a
2.3±1.4
21.047
0.000
Dyspnea
3.4±1.7a
3.4±1.4a
1.7±1.6
34.414
0.000
Table 2 Comparison of symptom scores ( xˉ ±s)
Notes: AD (+): patients with abdominal distension; constipation (+): patients with constipation; LGTS (-): patients without lower gastroin-
testinal tract symptoms (including abdominal distension and constipation). aP<0.01, compared with patients without lower gastrointestinal
tract symptoms (including abdominal distension and constipation).
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and 6MWT, the correlation coefficient being －0.501
(Table 5).
DISCUSSION
A complex disease, COPD is characterized by a variety
of pulmonary and extrapulmonary manifestations that
have impacts upon various aspects of affected patients'
lives. The most characteristic respiratory symptoms are
shortness of breath and limitation of mobility.18 In ad-
dition, patients with COPD may present with systemic
symptoms, including weight loss, reduced appetite,
skeletal muscle atrophy and dysfunction, depression
and/or anxiety. These systemic symptoms may be expe-
rienced by patients with different degrees of airway lim-
itation and have a wide range of deleterious effects on
acute exacerbations, clinical outcomes, hospitalization
and death; therefore, they should be managed appropri-
ately.19-21 Although lung function testing is essential for
COPD diagnosis and evaluation of efficacy of treat-
ment, it is far from being an appropriate marker for
quality of life and some aspects of improvement in re-
sponse to interventions. A more comprehensive ap-
proach that consers symptoms, body mass index, exer-
cise tolerance, exacerbations, impaired health-related
quality of life, and so on is commonly used for evalua-
tion of COPD.22
Because epidemiological data have shown that 50% of
deaths of patients with COPD are closely related to car-
diovascular complications,23 there have been numerous
studies on correlations between COPD and cardiovas-
cular disease. Constipation, one of the commonest low-
er gastrointestinal tract symptoms, is defined as defeca-
tion once per 3 or more days.24 Constipation can cause
abdominal pain and discomfort, gas, headaches, nau-
sea, and anorexia.25 Mostafa et al 26 found that constipa-
tion occurs in 83% of ICU patients and that 42% of
constipated patients fail to be weaned from mechanical
ventilation. Selective decontamination of the digestive
tract by oral administration of antibiotics or methyl cel-
lulose can reduce the morbidity of ventilator-associated
pneumonia, decrease the incidence of secondary respi-
ratory tract infection and shorten the length of ICU
stay.27
Patients with COPD are usually senile and limited in
mobility by their dyspnea. Because of their medica-
tions28 and mechanical ventilation,29 they tend to suffer
from lower gastrointestinal tract symptoms such as con-
stipation and abdominal distention. Wei et al 30 found
that patients with COPD and heart disease had gastro-
intestinal dynamic and hormonal disorders and that
these correlated closely with ventilatory dysfunction.
Powell et al 31 reported that patients with allergic rhini-
tis and asthma more commonly present with lower gas-
trointestinal tract symptoms than do patients with dia-
betes, osteoarthritis and rheumatoid arthritis. Al-
though some reports about constipation and abdomi-
nal distention in COPD patients have been published,
they focused on acute exacerbations of COPD and
there are few reports about the effects of such symp-
toms on COPD.32 In addition, there has been no re-
search on any correlations between these symptoms
and quality of life, symptoms or progression of COPD
in COPD patients.
The present study used a cross-sectional questionnaire
survey to assess the percentage of COPD patients with
AD
Constipation
Cough
Sputum
Dyspnea
FAE
6MWD
SGRQ total
SGRQ
symptom
SGRQ
activity
SGRQ
impact
AD
1
0.387a
0.410a
0.420a
0.508a
0.226a
－0.501a
0.462a
0.298a
0.295a
0.512a
Constipation
-
1
0.355a
0.436a
0.337a
0.260a
－0.517a
-0.137
0.187b
0.372a
0.411a
Cough
-
-
1
0.600a
0.379a
0.312a
－0.194b
0.264a
0.353a
0.115
0.269a
Sputum
-
-
-
1
0.303a
0.269a
－0.116
0.337a
0.246a
0.205a
0.376a
Dyspnea
-
-
-
-
1
0.205a
－0.394a
0.478a
0.321a
0.401a
0.472a
FAE
-
-
-
-
-
1
－0.171b
0.032
0.038
0.058
0.014
6MWD
-
-
-
-
-
-
1
－0.416a
－0.339a
－0.283a
－0.440a
SGRQ
Total
-
-
-
-
-
-
-
1
0.691a
0.880a
0.960a
SGRQ
Symptom
-
-
-
-
-
-
-
-
1
0.491a
0.571a
SGRQ
Activity
-
-
-
-
-
-
-
-
-
1
0.759a
SGRQ
Impact
-
-
-
-
-
-
-
-
-
-
1
Table 5 Correlation between lower gastrointestinal tract symptoms (including abdominal distension and constipation) and HRQL
Notes: aCorrelation is significant at the 0.01 level (2-tailed). bCorrelation is significant at the 0.05 level (2-tailed). AD: abdominal disten-
tion; FAE: frequency of acute exacerbations; HRQL: health-related quality of life; 6MWD: 6-minute walking distance; SGRQ: St.
George's respiratory questionnaire.
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constipation and abdominal distention and identify re-
lationships between lower gastrointestinal tract symp-
toms (constipation and abdominal distention) and
scores for major pulmonary symptoms (cough, sputum
and wheezing), 6MWD, SGRQ, and frequency of AE-
COPD to develop guidelines for prevention and treat-
ment of COPD symptoms. The 191 patients with sta-
ble COPD were recruited from four three-level class A
CM hospitals in China and, in addition to pulmonary
symptoms (cough, sputum and wheezing), 39.79%
and 40.31% of them were found to have constipation
and abdominal distention, respectively. In patients
with constipation and abdominal distention, pulmo-
nary symptoms (cough, sputum and wheezing) were
significantly more severe, the frequency of acute exacer-
bations of COPD significantly higher, scores for
SGRQ greater, and 6MWT shorter than in patients
without these lower abdominal symptoms. Pearson cor-
relation analysis showed a significant positive correla-
tion between constipation and abdominal distention
and scores for pulmonary symptoms (cough, sputum
and wheezing) and SGRQ and for frequency of acute
exacerbations of COPD. There was also a significant
negative correlation between constipation and abdomi-
nal distention and 6MWT. These findings suggest that
there is a close relationship between the condition of
stable COPD patients and lower gastrointestinal tract
symptoms such as constipation and abdominal disten-
tion. Our findings suggest that alleviation or preven-
tion of these lower abdominal symptoms and mainte-
nance of regular bowel movement by use of laxatives,
adjustment to dietary patterns and ventral massage
may improve COPD patients' respiratory symptoms
and QOL.
This study has three limitations. First, because it was a
cross-sectional study, our findings of statistically signifi-
cant correlations between constipation and abdominal
distention and scores for pulmonary symptoms (cough,
sputum and wheezing) and SGRQ, frequency of acute
exacerbations of COPD, and 6MWT do not imply
that this relationship is causal. However, we consider it
undeniable that constipation and abdominal distention
affect the condition of COPD patients. Professor Nan-
shan Zhong, a well-known respiratory specialist and ac-
ademic in China, once stated that constipation does af-
fect COPD patients' breathing and conversely, good di-
gestion and bowel habits improve their breathing.33
While anecdotal, this statement stemmed from exten-
sive clinical experience and is therefore likely accurate.
Second, there was recall bias in this study because the
patients themselves primarily reported and assessed
their symptoms. In recent decades, however, patient-re-
ported outcomes have become more widely used34 for
assessing subjective symptoms such as cough, sputum
and wheezing, QOL and health-related QOL.
Third, this was a relatively small study compared with
other large-scale COPD studies. Nonetheless, we ob-
tained sufficient data to confirm our hypothesis.
The lower gastrointestinal tract symptoms such as con-
stipation and abdominal distention can affect pulmo-
nary symptoms of patients with COPD, incidence of
acute exacerbations of COPD and QOL. Thus, it is im-
portant to focus on managing lower gastrointestinal
tract symptoms and keeping the intestinal tract clear to
improve COPD patients' general condition and QOL.
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